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ke Atas Pengekspresan Minigenom Virus Nipah)
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ABSTRACT
Nipah virus has been identified as the causative agent responsible for an outbreak of fatal human viral encephalitis in 
Malaysia and Singapore in 1998 to 1999. In vitro replication assays with Nipah virus minigenome carrying CAT gene 
(chloramphenicol acetyltransferase) has been developed without the use of infectious virus to allow further study of 
the replication of Nipah virus in vitro. It has been reported that the viral RNA replication and transcription activity of 
paramyxoviruses are controlled by essential sequences located in the terminal regions of viral genomic and antigenomic 
RNAs. In this study, single base substitution was carried out on the Nipah virus minigenome separately at the three guanine 
residues (G) located in positions 79, 85 and 91 of the leader promoter within the 5’ non-translated region (NTR) of the 
nucleocapsid gene (N) mRNA region. The guanine residues of these positions were substituted with the cytosine (C) or 
adenine (A) residue, respectively by using the overlapping PCR-mediated mutagenesis method. The resultant mutants 
containing the desired point mutation were confirmed by sequencing. The mutants were analyzed to determine the effect 
of substitution mutation on the viral transcription activity of the minigenome. It was found that the substitution of G at 
positions 79 and 85 decreased the efficiency of transcription of Nipah virus minigenome while the substitution of G at 
position 91 did not. Our findings also showed that the effect of transition mutation gave more impact than the transversion 
mutation in term of suppression effect upon the transcription activity of minigenome.
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ABS TRAK
Virus Nipah telah dikenalpasti sebagai agen yang menyebabkan letusan jangkitan ensefalitis yang boleh membawa maut 
di kalangan manusia di Malaysia dan Singapura dalam tahun 1998 hingga 1999. Asai replikasi secara in vitro yang 
terdiri daripada minigenom virus Nipah yang mengandungi penanda gen CAT (chloramphenicol acetyltransferase) telah 
dibangunkan tanpa melibatkan virus berjangkit, dengan tujuan untuk mengkaji replikasi virus Nipah secara in vitro. 
Aktiviti replikasi RNA dan transkripsi paramyxovirus telah dilaporkan dikawal oleh jujukan penting yang terkandung 
dalam kawasan hujung RNA genom dan antigenom virus. Dalam kajian ini, mutagenesis secara penggantian bes tunggal 
telah dilakukan ke atas minigenom virus Nipah secara berasingan dalam kawasan promoter pemimpin, yakni tiga 
residu guanina (G) yang terletak di posisi 79, 85 dan 91 dalam kawasan 5’ NTR mRNA gen nukleokapsid (N). Residu 
G tersebut telah digantikan dengan residu sitosina (C) dan adenina (A) masing-masing dengan menggunakan kaedah 
mutagenesis berasaskan tindak balas berantai polimerase (PCR) bertindih. Mutan-mutan terhasil yang mengandungi 
mutasi titik yang dikehendaki telah dikenalpastikan melalui penjujukan DNA. Mutan-mutan tersebut telah dianalisis untuk 
menentu kesan mutasi penukargantian tersebut ke atas aktiviti transkripsi minigenom virus Nipah. Didapati bahawa 
penukargantian residu G pada posisi 79 dan 85 menurunkan kecekapan aktiviti transkripsi minigenom virus Nipah 
manakala penukargantian residu G pada posisi 91 tidak memberikan kesan tersebut. Penemuan ini juga menunjukkan 
kesan mutasi transisi memberikan kesan yang lebih ketara daripada kesan mutasi transversi daripada segi kesan 
penahanan ke atas aktiviti transkripsi minigenom virus.
Kata kunci: Jujukan pemimpin; minigenom; mutagenesis; virus Nipah
INTRODUCTION
In September 1998, a fatal viral encephalitis outbreak in 
peninsular Malaysia was first reported. Consequently, 
a new virus, termed Nipah virus, was identified as the 
causative agent of the fatal viral encephalitis outbreak in 
human (Chua et al. 1999). Nipah virus was first emerged 
in Kinta district, Perak which then spread to Sikamat and 
Bukit Pelandok in Negeri Sembilan and Sungai Pelandok in 
Selangor. In 5 March 1999, Nipah virus was first isolated in 
Malaysia by the researchers from the Faculty of Medicine, 
University of Malaya (Ministry of Health Malaysia 2001). 
Nipah virus is named in accordance with the location where 
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it was first detected in Malaysia, which is Kampong Sungai 
Nipah in Bukit Pelandok.
 Nipah virus is an enveloped, non-segmented, negative-
stranded RNA paramyxovirus belonging to the new genus, 
Henipavirus within the subfamily Paramyxovirinae of the 
family Paramyxoviridae (Harcourt et al. 2000; Harcout 
et al. 2001; Mayo 2002; Wang et al. 2001). The genome 
of Nipah virus comprised of 18,246 nucleotides has 
been assigned as the largest genomes within the family 
Paramyxoviridae (Harcout et al. 2001). The genome of 
Nipah virus consists of six transcription units encoding 
six major structural proteins, the nucleocapsid (N), 
phophoprotein (P), matrix protein (M), fusion protein (F), 
glycoprotein (G) and large protein (L) or RNA polymerase 
that are ordered in 3’- N-P-M-F-G-L -5’. The P gene of 
Nipah virus is predicted to encode the multiple proteins 
namely P, V, W and C protein (Harcout et al. 2000; Wang 
et al. 2001).
 In the case of genome of Nipah virus, it is non-
segmented. Therefore, the viral genomic RNA first is 
transcribed into different multiple mRNA, which is termed 
as sub-genomic mRNA after the entry of ribonucleoprotein 
(RNP) into the cytoplasm. The synthesis of multiple mRNA 
occurs via stop-start mechanism at the intergenic region 
of viral genome. As a result, each of the six viral genes is 
transcribed in one by one into six viral mRNA, respectively 
which are then translated to produce the six major viral 
proteins in the cytoplasm. The viral transcription process 
is switched to RNA replication process under the control 
of viral nucleocapsid protein (N). As the protein synthesis 
proceeds, the level of N protein is increased and level of N 
protein become high enough to associate with the nascent 
positive-sense strand RNA through interaction with the P 
protein at specific site within the leader region, suppressing 
the stop-start mechanism. Thus the polyadenylation and 
mRNA cleavage are blocked. This will allow the synthesis 
of full-length positive-sense strand RNA which is known as 
antigenomic RNA. The encapsidated full-length positive-
sense strand RNA then serves as template for progeny 
genomic RNA synthesis (Flint et al. 2000; Wagner & 
Hewlett 2004). 
 The terminal regions of the genomic and antigenomic 
RNAs of the paramyxovirus are known to contain essential 
sequences for directing viral RNA replication as well 
as the transcription activity. The 3’ end of genomic 
RNA is known as leader (Le) promoter which directs 
the viral transcription activity as well as synthesis and 
encapsidation of antigenomic RNA, whereas the 3’ end of 
the antigenomic RNA is known as trailer complementary 
(Trc) promoter which directs the synthesis of progeny 
genomic RNA (Hoffman & Banerjee 2000; Kawaoka 2004; 
Marcos et al. 2004; Peeples & Collins 2000; Walpita & 
Peters 2007). There are two essential elements found in 
the genomic and antigenomic RNA replication promoter, 
the conserved region I which located at 3’ end of leader 
promoter and the conserved region II which located in 5’ 
NTR of the N gene mRNA region of viral genome (Marcos 
et al. 2004; Tapparel et al. 1998). Walpita and Peters 
(2007) proposed that the sequence elements located in the 
non-coding region within the 5’-end of trailer promoter 
(antigenomic promoter) of Nipah virus genome control 
the genome synthesis, and they reported that there was a 
conserved region at nucleotide 1 – 12 and 79 – 91 in the 
antigenomic promoter of Nipah virus which appeared to 
be critical.
 The in vitro replication assays with Nipah virus 
minigenome carrying CAT gene has been developed 
without the use of infectious virus to allow further study 
on the replication of Nipah virus in vitro (Figure 1). In 
this study, the conserved region II of the leader promoter 
(genomic promoter) was focused in which the three 
guanine residues (G) located in positions 79, 85 and 91 of 
the leader promoter within the 5’ NTR of the N gene mRNA 
region were substituted with the cytosine (C) or adenine 
(A) residue, respectively (Figure 2). Here, we investigated 
whether the G residues at positions 79, 85 and 91 of the 
leader promoter play any role in the transcription of Nipah 
virus. As for this, we carried out the mutational analysis on 
these positions where the point mutations were generated. 
Besides, we wanted to compare the effects of transversion 
and the transition mutations generated at these positions 
in efficiency of viral transcription as well.
MATERIALS AND METHODS
OVERLAPPING PCR-MEDIATED MUTAGENESIS
The point mutations were generated on negative-
sense minireplicon of Nipah virus, pMGNiVR6, by 
overlapping PCR-mediated mutagenesis in which the 
degenerate primers were used. The overlapping PCR-
mediated mutagenesis involved three sets of PCR, that 
were PCR phase I, PCR phase II and PCR phase III. 
The primers used to amplify the whole Nipah virus 
minigenome inserted in pUC19 vector were forward 
primer 5’- ACCCGGGGATCCACTAGAGTCAAAA 
-3’ which encoded a SmaI restriction site (in underlined) 
and reverse primer 5’- TAATACGACTCACTATA 
GGGACCGAACAA -3’. Mutations at positions 79, 
85 and 91 of the leader promoter were generated using 
designed primers which contain the desired single 
base substitution. To obtain the altered Nipah virus 
minigenome fragments, the primers used in PCR phase 
I to amplify the downstream sequence of Nipah virus 
minigenome containing the mutation site were reverse 
primer and mutated forward primer 5’- CACTTTTG(C/A)
TCTTGGTATTGGATCCTCA -3’ (position 79), 5’- 
CACTTTT GGTCTTG(C/A)TATTGGATCCTC -3’ 
(position 85) or 5’- CACTTTTGGTCTTG GTATTG(C/A)
ATCCTC -3’ (position 91), while the primers used 
in PCR phase II to amplify the upstream sequence 
containing mutation site were forward primer and mutated 
reverse primer 5’- GAGGATCCAATACCAAGA(T/G)
CAAAAGTG -3’ (position 79), 5’- GAGGATCCAATA(T/G)
CAAGACCAAAAGTG -3’ (position 85) or 5’- 
CTTGAGGAT(T/G)CAATACCAAGACCAAAAG -3’ 
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(position 91). The boldface nucleotides (in bracket) in 
mutated primers represent the substitution of G with C 
or A residue, respectively. In PCR phase III, the purified 
overlapping DNA fragments resulted from PCR phase I and 
phase II were then combined via overlapping, extended and 
amplified using the forward primer and reverse primer to 
produce the full-length of altered Nipah virus minigenome. 
All of the PCR were carried out by using the Taq DNA 
polymerase (Vivantis). The PCR products were purified by 
using the PCR Products Purification QIAquick kit or Gel 
Extraction QIAquick kit (Qiagen).
CONSTRUCTION OF MUTANT PLASMIDS
The PCR product resulted from the PCR phase III was a 
1095 bp fragment encoded a SmaI restriction site at the 
5’end of fragment. The altered minigenome fragments were 
cloned into pTZ57R cloning vector according to the InsT/
AcloneTM PCR Product Cloning kit’s protocol (Fermentas) 
and subsequently were transformed into E. coli DH5α host 
cells as previously described (Sambrook & Rusell 2001). 
The recombinant plasmids were extracted from the positive 
clones by using the Extraction QIAprep Spin Miniprep 
kit (Qiagen), and were then analyzed using agarose gel 
electrophoresis and restriction enzyme digestion. The 
recombinant plasmids were digested with SmaI in single 
digestion or SmaI and KpnI in double digestion. The 
sequence of altered minigenome fragments finally were 
confirmed via DNA sequencing.
TRANSFECTION
Approximately 1 × 105 cells/mL of Vero cells were 
plated into 18 mL of Dulbecco’s Modified Eagle medium 
(Gibco) supplemented with 10% fetal bovine serum (PAA) 
and grown to 90-95% confluence in T-75 culture flask 
FIGURE 1. Schematic diagram of structure of the Nipah virus minireplicon, pMGNiVR6. In this minigenome system, all of the viral 
genes were replaced with a reporter gene, the CAT gene flanked by transcription start sequence of N gene, the 5’ NTR of the N gene 
mRNA, the 3’ NTR of the L gene mRNA and the transcription stop sequence of L gene. Additional four bases were added after the 
3’ end of CAT gene to make the length of minigenome evenly divisible by six. Transcription of minigenome from the plasmid is 
directed by a T7 RNA polymerase promoter. When the minigenome is transcribed by the T7 RNA polymerase in 3’ to 5’ direction, 
the negative-sense of primary transcripts are synthesized, which is contain sequence encoding the viral trailer region, a gene end 
signal (GE), part of 3’ NTR of the L gene mRNA, the CAT gene, part of 5’ NTR of the N gene mRNA, a gene start signal (GS), 
the viral leader region, the hepatitis delta virus ribozyme, and the T7 RNA polymerase termination signal
FIGURE 2. The cDNA sequence of leader promoter of Nipah virus located at the 5’ end of the minigenome. 
The underlined and boldfaced nucleotides were substituted with C or A residue
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by incubating the cells at 37oC in 5% carbon dioxide 
condition. The cells in each flask were transfected with 4.5 
μg pNiV-N, 3.0 μg pNiV-P, 1.5 μg pNiV-L, 7.5 μg pTriEX-
T7 and 13.5 μg minigenome plasmid (pMGNiVR6) 
by using the Lipofectamine 2000 Transfection reagent 
(Invitrogen) according to the manufacturer’s protocol. 
The pMGNiVR6, pNiV-N, pNiV-P, pNiV-L and pTriEX-
T7 were kindly provided by Dr. Shahreza from Universiti 
Malaysia Terengganu. For experimental controls, the 
wild-type minigenome plasmid was co-transfected with 
the pNiV-N, pNiV-P or pNiV-L alone as indicated above. 
The plates were incubated at 37oC in the presence of 
5% carbon dioxide. Medium was replaced with new 
Dulbecco’s Modified Eagle medium supplemented with 
10% fetal bovine serum after 5 h of incubation period. The 
cells were subsequently incubated at 37oC in the presence 
of 5% carbon dioxide for a total of 48 h. The cells were 
then harvested for the CAT activity.
WESTERN BLoTTING AND CAT ELISA ASSAy
The cells were scraped into the medium and pooled. The 
harvested cells were then lysed by using CAT lysis buffer 
which provided by CAT ELISA kit (Roche). After incubation 
of 30 min at room temperature, the lysate was centrifuged 
at 4,000 rpm for 15 min at 4oC. The supernatant was then 
analyzed via Western blotting. The bound CAT protein was 
detected by primary antibody anti-CAT-DIG followed by 
secondary antibody anti-DIG-POD, which were provided 
by CAT ELISA kit (Roche). The band detection was carried 
out according to the manufacturer’s protocol. The CAT 
ELISA assay was performed by using the CAT ELISA kit in 
accordance with the manufacturer’s protocol, to determine 
the CAT concentration in cytoplasmic extracts.
RESULTS AND DISCUSSION
All of the viruses belonging to the subfamily 
Paramyxovirinae have genomes which are divisible by 
six, conforming to the “rule of six”. The RNA replication of 
those viruses is efficient only if the genome is multiple of 
six (Calain & Roux 1993). The in vitro replication assays 
with Nipah virus minigenome carrying CAT gene has been 
developed to study the replication of Nipah virus in vitro. 
Therefore, the Nipah virus minigenome that used in this 
study is divisible by six, in which the four bases were 
added after the 3’ end of CAT gene, extending the length 
of minigenome to 876 nucleotides. 
 Transfection of Nipah virus minigenome plasmid 
together with the support plasmids and plasmid encoding 
T7 RNA polymerase, pTriEX-T7 into the Vero cells resulted 
in RNA replication and transcription of the minigenome. 
When the described minigenome system is transfected into 
host cells, the naked minigenomic RNA was synthesized 
from the transfected plasmid carrying the Nipah virus 
minigenome by T7 RNA polymerase expressed from the 
co-transfected T7-encoded plasmid. The plasmid-derived 
minigenomic RNA was a negative-sense of primary 
transcript with 876 nucleotides in size. The 3’ end of 
the minigenomic RNA was self-cleavaged by a hepatitis 
delta virus ribozyme sequence located adjacent to the 
leader region of the minigenome, whilst the 5’ end of the 
minigenomic RNA was created correctly mediated by a 
T7 promoter sequence that placed adjacent to the trailer 
region (Figure 1). Thus result in the precise ends of the 
minigenome transcript. 
 The other co-transfected support plasmids carrying N, 
P and L gene of Nipah virus individually were transcribed 
by T7 RNA polymerase and then translated into the support 
proteins. This process continues until sufficient levels of 
support proteins are retained to form the ribonucleoprotein 
(RNP), in which the N and P are involved in encapsidation 
of minigenomic RNA. The encapsidated plasmid-derived 
minigenomic RNA then serves as template for the synthesis 
of antigenomic RNA and the transcription of viral genes. 
The synthesized full-length of antigenomic RNA will then 
be encapsidated and served as template for the synthesis 
of progeny genomic RNA. As in this minigenome system, 
the viral genes were replaced with a reporter gene namely 
chloramphenicol acetyltransferase (CAT) gene (Figure 1). 
Therefore, CAT gene mRNA strands will be synthesized 
and subsequently were translated into the CAT protein. 
 In our initial studies, we focused on the step of viral 
transcription activity. The three G residues located in the 
5’ NTR of the N gene mRNA region at the positions 79, 85 
and 91 of the leader promoter were substituted with the C 
or A residue, respectively. The resultant mutants containing 
desired point mutation were confirmed by sequencing 
(Figure 3). The mutants were then analyzed by measuring 
the CAT protein levels relative to wild-type, in order to 
determine the effect of point mutation on the efficiency of 
viral transcription activity of the minigenome. Thus the CAT 
activity could be indirectly measured for the transcription 
activity of minigenome. 
 To analyze the minigenome transcription, the 
transfected cells were harvested after 48 h posttransfection 
and then were lysed to obtain the cellular total protein. 
The lysate were analyzed using Western blotting to detect 
the presence of CAT protein. Detection of CAT protein 
reflected the synthesis of CAT mRNA from the minigenome, 
showing that the minigenome system is functioning and 
be activated in the host cells. Further analysis of CAT 
expression was conducted through the CAT ELISA assay 
in order to determine the level of expressed CAT protein 
in each sample. Differences of CAT protein levels were 
interpreted to reflect the efficiency of viral transcription 
from the mutated leader promoter.
 From the results gained from Western blotting analysis 
(Figure 4), there was no CAT protein detected in non-
transfected cells and the sample omitting of wild-type 
minigenome plasmid but it was detected in the sample 
with wild-type minigenome, as expected. There was a very 
little or no CAT protein detected from mutant MGNiV79C, 
MGNiV79A, MGNiV85C and MGNiV85A. The results 
of CAT ELISA assay showed that the level of CAT protein 
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expressed in mutant MGNiV79 and MGNiV85 were 
lower than the CAT protein level of wild-type minigenome 
plasmid (Figure 4). The mutant MGNiV85A gave the 
highest decrease level of CAT protein among the mutants, 
with a decrement of 37.15% if compared to that of the 
wild-type. The other mutants MGNiV79C, MGNiV79A 
and MGNiV85C gave decreased level of CAT protein with 
1.54%, 20.07% and 20.16% respectively with respect to 
the CAT protein level of wild-type. However, a detectable 
level of CAT protein was observed in mutant MGNiV91C 
and MGNiV91A. There was a difference in mutation 
effect upon the CAT expression between transition and 
transvertion mutations. The transition mutation generated 
at positions 79 and 85 results in a higher decrement of CAT 
protein if compared to that of the transversion mutation. 
But the substitution of G to A residue at position 91 
showed the highest expression of CAT protein among the 
mutants with 60.31% higher than the wild-type, whilst the 
substitution of G to C residue gave the CAT protein level 
with 26.25% higher than the wild-type.
 Halpin et al. (2004) have demonstrated that no CAT 
protein was detected in the absence of the plasmid encoding 
N gene, P gene or L gene of Nipah virus. Nevertheless, in 
our experimental studies, There was low CAT protein level 
detected from sample in which the N plasmid were omitted 
(Figure 4). We have shown that there was a detectable 
level of CAT protein in the absence of L protein (data not 
shown). This result indicated that the viral genome may 
FIGURE 3.  Sequence analysis of single base mutations in pMGNiVR6 at positions 79, 85 and 91. The target sites within the leader 
promoter of minigenome were substituted correctly with the desired bases. (i): pMGNiV79C; (ii): pMGNiV79A; 
(iii): pMGNiV85C; (iv): pMGNiV85A; (v): pMGNiV91C; (vi): pMGNiV91A
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still be able to assemble into the nucleocapsid by solely N 
and P protein supplied in trans. 
 The N protein plays an important role in encapsidation 
of viral RNA genome and thus regulates the viral 
transcription and replication (Eshaghi et al. 2005). The 
“rule of six” has been proposed as a requirement for 
N protein to bind exactly six nucleotides to the viral 
genome (Calain & Roux 1993). The binding of N protein 
together with P protein to the genomic RNA forms the 
ribonucleoprotein (RNP) complex that is associated with 
the viral RNA polymerase (L protein), which serves as the 
functional template for both viral transcription and RNA 
replication (Hoffman & Banerjee 2000; Kawaoka 2004). 
The encapsidated genomic RNA serves as template for 
synthesis of positive-sense RNAs, namely the sub-genomic 
viral mRNAs and the antigenomic RNA. The synthesized 
full-length antigenomic RNAs serve as efficient templates 
for RNA replication only when they are encapsidated with 
the N protein. 
 Tapparel et al. (1998) proposed the existence of three 
N protein binding sites at the bases 79 – 84, 85 – 90 and 
91 – 96 located in the 5’ NTR of the N gene mRNA region 
of Sendai virus, which may serves as a nucleation site for 
encapsidation of the RNA by the N protein. The first base 
within each hexamer must be a G residue and therefore 
only the positions 79, 85 and 91 appear to be critical. 
These three positions of the Sendai virus replication 
promoter have been shown to be critical bases in three N 
binding hexamers. The mutations at these G residues were 
also critical for RNA replication of Human Parainfluenza 




FIGURE 4. Expression of CAT protein by the mutants. Vero cells were transfected with Nipah virus minigenome plasmid containing point 
mutation together with the helper plasmids (pNiV-N, pNiV-P and pNiV-L) and plasmid encoding T7 RNA polymerase as previously 
described. The lysate of cells transfected with pMutNiV79C (lane 1), pMutNiV79A (lane 2), pMutNiV85C (lane 3), pMutNiV85A (lane 
4), pMutNiV91C (lane 5), pMutNiV91A (lane 6) and wild-type minigenome (lane 7) were prepared after 48 hours posttransfection. 
The lysates were then analyzed for their CAT expression via Western blotting and CAT ELISA assay. Lane 9, 10 and 11 represented the 
samples in which the pNiV-N, pNiV-P and wild-type minigenome were omitted in transfection mixtures, respectively. Sample in lane 
8 and 12 represented the positive control, in which the CAT protein provided by CAT ELISA kit was used. Lysate of non-transfected 
cells (lane 13) was also assayed for CAT expression. (a) Western blotting analysis of CAT expression of mutant samples. (b) The 
concentration of CAT protein in cytoplasmic extracts was measured by using CAT ELISA and expressed as a concentration 
relative to the wild-type minigenome with the standard error indicated by the vertical bars 
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 From our result of mutational analysis, we found that 
the nucleotides at the positions 79 and 85 could be critical 
in the genome encapsidation process, where the transition 
or transversion mutation was generated at these positions, 
respectively. The low CAT protein level relative to wild-type 
observed in mutant MGNiV79 and MGNiV85 give rise to 
an initial interpretation that the substitution of G with C or 
A residue at these positions might block the formation of 
functional template for viral transcription by preventing the 
N protein from binding to the 5’ NTR of the N gene mRNA 
region of plasmid-derived minigenomic RNA. In contrast 
to mutant MGNiV79 and MGNiV85, the substitution of G 
residue at position 91 had not given any significant effect 
on CAT expression level. However, this interpretation have 
to be confirmed and further analyzed by examining the 
levels of encapsidated minigenomic RNA in future.
 We assumed that there were certain nucleotides located 
in 5’ NTR of the N gene mRNA region which might play 
a role in encapsidation of viral genomic RNA as well 
as antigenomic RNA. We would expect that nucleotide 
located at positions 79, 85 and 91 might also affect the 
viral RNA replication as well. Hoffman and Banerjee 
(2000) have shown that mutations at these G residues are 
critical for RNA replication of Human Parainfluenza virus 
type 3 (HPIV3), where the mutation at positions 85 and 
91 completely abrogated the antigenomic RNA synthesis, 
but mutation at position 79 still allows some antigenomic 
RNA synthesis (Figure 5). Further studies will be carried 
out to determine the effects of these mutations on the RNA 
replication of minigenome.
 It has been reported that the N, P and L proteins 
are sufficient to promote efficient viral replication as 
well as transcription of virus belonging to subfamily 
Paramyxovirinae (Durbin et al. 1997; Halpin et al. 2004; 
Kawaoka 2004). However, our experimental results 
showed that the CAT protein was detected in the absence 
of L protein. Since the plasmid-derived genomic RNA 
serves as template for the viral transcription only when it is 
encapsidated by the N protein together with the P protein, 
this observation suggests that the viral transcription of CAT 
gene  occurred as the plasmid-derived genomic RNA was 
encapsidated and functioned as a template for the viral 
transcription and the synthesis of antigenomic RNA as 
well. Hence, the plasmid-derived minigenome of Nipah 
virus synthesized in the presence of N and P could be 
encapsidated independent of functional viral polymerase. 
Nevertheless, the levels of encapsidated minigenomic RNA 
have to be examined to firmly conclude this conclusion. 
The encapsidated plasmid-derived minigenomic RNA of 
Respiratory Syncytial virus (RSV) was detected in the 
presence of N and P proteins together with non-functional 
L protein, thus the plasmid-derived minigenomic RNA 
was capable to assemble into nucleocapsid by N and P 
proteins, the so-called encapsidation process (Peeples 
and Collins 2000). The support plasmid bearing N and P 
gene are necessary for achieving the efficient minigenome 
transcription of Nipah virus while the effect of L gene is 
less vital. However, no conclusiom can be made clearly 
on the effect of L gene as it is not the scope of our study.
 As a conclusion, substitution of G residue at positions 
79 and 85 may comprise the suppression effect upon the 
transcription of Nipah virus based on the results obtained 
from our experiments. Substitution of G at position 91 did 
not suppress the viral transcription. The other nucleotides 
located in conserved region II of Nipah virus will be 
studied as well, in order to find out the conserved sequences 
involved in the encapsidation as well as the RNA replication 
of Nipah virus. Since the constructed minigenome system 
could be used to produce the full-length of infectious 
recombinant virus from a cDNA of Nipah virus genome 
or antigenome, this will allow the future analysis of leader 
mutation generated in full-length of Nipah virus genome to 
be conducted. Thus, the correlation between the replication 
activity of the mutated minigenome and the ability of 
recombinant virus carrying that mutation to replicate 
could be observed. The recombinant virus with reduced 
replicative ability could be essential for development as a 
vaccine candidate.
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